Lead Product(s): Polysaccharide iron complex
Therapeutic Area: Hematology Product Name: Li Fei Neng
Highest Development Status: Approved Product Type: Small molecule
Partner/Sponsor/Collaborator: RTW Investments
Deal Size: $181.0 million Upfront Cash: Undisclosed
Deal Type: Series D Financing December 08, 2020
Proceeds from the financing will be used in the ongoing research and development of Nuance's existing products and business development of potential new assets.